Not in the pink of health

The past year has been a roller-coaster ride for domestic pharmaceutical companies, with many manufacturing facilities coming under the international regulatory scanner for alleged deviation from norms. A look at how these developments have affected operations at three drug facilities:

UNDER LENS
Indian drug makers that received US FDA import alerts in 2013

• Amsal Chem, Ankleshwar, Gujarat- 1 unit
• Global Calcium, Hosur, Tamil Nadu- 2 units
• Global Calcium, Bangalore- 3 units
• Kamud Drugs, Sangli, Maharashtra- 1 unit
• Konduskar Laboratories,Kagal, Maharashtra - 1 unit
• Micro Labs, Bangalore- 1 unit
• Promed Exports, Solan, Himachal Pradesh- 1 unit
• RPG Life Sciences, Ankleshwar, Gujarat- 1 unit
• RPG Life Sciences, Thane,Maharashtra- 1 unit
• Ranbaxy Laboratories, Mohali, Punjab- 2 units
• Smruthi Organics, Solapur, Maharashtra- 1 unit
• Unique Chemicals,Mumbai, Maharashtra- 1 unit
• Vignesh Life Sciences, Hyderabad, Andhra Pradesh- 1 unit
• Vignesh Life Sciences Bellary, Karnataka- 1 unit
• Wockhardt, Aurangabad, Maharashtra-1 unit

Source: US FDA website